MiRNA-150 was shown to be highly expressed in GC, breast cancer, lung cancer, and endometrial cancer and to function as an oncogene in these tumors by repressing the expression of tumor suppressor genes such as P2X7 and p53 [26, 27]. The gene discussed is TP53; the disease is lung carcinoma.